Tag Archives: Inc.

U.S. FDA’s Nonprescription Drugs Advisory Committee recommends approval of Sanofi’s Nasacort AQ Nasal Spray for over-the-counter use in the U.S.

Posted on 6, August 2013 by

Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children  Paris, France, 06-8-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) voted 10 to … Read the full press release →

Posted in Business, France, Government, Healthcare, Pharma & Biotech, Science

Tagged , , , , , , , , , , , , , , , , , , , , , , , ,

Anheuser-Busch InBev disclosure made according to the requirements of the Belgian Law of 2 May 2007

Posted on 3, July 2013 by

Brussels, 3-7-2013 — /europawire.eu/ — Anheuser-Busch InBev (Euronext: ABI) (NYSE: BUD) discloses the notification of significant shareholdings that it has received according to the Belgian Law of 2 May 2007 on the disclosure of significant shareholdings in listed companies. According to its … Read the full press release →

Posted in Belgium, Business, Financial, Food & Beverage, Government, Investment

Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

ThyssenKrupp Elevator acquired all assets of Cleveland, Ohio-based Edmonds Elevator, Inc.

Posted on 2, July 2013 by

2-7-2013 — /europawire.eu/ — ThyssenKrupp Elevator has acquired all assets of Cleveland, Ohio-based Edmonds Elevator, Inc. The US company, founded in 1875, provides elevator maintenance, repair and modernization services. “The acquisition continues our international growth strategy and strengthens our service business … Read the full press release →

Posted in Business, Electronics & Machinery, Financial, Germany, Industrial, Investment

Tagged , , , ,

MedImmune, NGM Biopharmaceuticals in exclusive agreement to discover, develop and commercialise therapies for diabetes and obesity

Posted on 25, June 2013 by

25-6-2013 — /europawire.eu/ — AstraZeneca today announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive agreement to discover, develop and commercialise novel therapeutics from NGM’s enteroendocrine cell (EEC) programme for the … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Science, United Kingdom

Tagged , , , , , , , ,